1. IL‐1β and IL‐18: inflammatory markers or mediators of hypertension?. (December 2014) Authors: Krishnan, S M; Sobey, C G; Latz, E; Mansell, A; Drummond, G R Journal: British journal of pharmacology Issue: Volume 171:Number 24(2014:Dec.) Page Start: 5589 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Inflammasome activity is essential for one kidney/deoxycorticosterone acetate/salt‐induced hypertension in mice. (31st July 2015) Authors: Krishnan, S M; Dowling, J K; Ling, Y H; Diep, H; Chan, C T; Ferens, D; Kett, M M; Pinar, A; Samuel, C S; Vinh, A; Arumugam, T V; Hewitson, T D; Kemp‐Harper, B K; Robertson, A A B; Cooper, M A; Latz, E; Mansell, A; Sobey, C G; Drummond, G R Other Names: Stewart AG guestEditor.; Beart PM guestEditor. Journal: British journal of pharmacology Issue: Volume 173:Number 4(2016:Feb.) Page Start: 752 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PTH-134 Reduced calcineurin inhibitor exposure early after liver transplantation protects against renal dysfunction independently of the use of basiliximab induction therapy. (22nd June 2015) Authors: Onali, S; Mansell, A; Aspite, S; De Luca, L; Tsochatzis, E; O'Beirne, D. Patch, J; Thorburn, D; Pinzani, M; Manousou, P Journal: Gut Issue: Volume 64(2015)Supplement 1 Page Start: A467 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Response to aerosol salbutamol, SCH 1000, and placebo in cystic fibrosis. Issue 7 (July 1980) Authors: Kattan, M; Mansell, A; Levison, H; Corey, M; Krastins, I R Journal: Thorax Issue: Volume 35:Issue 7(1980) Page Start: 531 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗